TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from pneumonia, risk of long COVID after two vaccine doses, and peripheral neuropathy in long COVID.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Vaccine effectiveness 5-11 year olds (medRxiv)
- Vaccine effectiveness vs ED and UCE 5-12 year olds (medRxiv)
- Children affected by COVID (Lancet)
- Accuracy of rapid antigen tests (medRxiv)
- COVID community levels (CDC)
- Therapeutics guidelines (WHO)
- Mortality among SOT (Clin Inf Dis)
- Long COVID after two vaccine doses (medRxiv)
- Peripheral neuropathy in COVID patients (Neurology)
- Letters read on TWiV 872
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]